What went wrong for orthopedics at J&J MedTech and what might the future hold for the standalone DePuy Synthes?
What went wrong for orthopedics at J&J MedTech and what might the future hold for the standalone DePuy Synthes?
Five things we’re watching as the orthopedic market’s competitive landscape evolves and we move into the second half of 2025.
Our chart of the month tracks spine M&A activity over the last decade, including the seven deals done so far in 2025.
The range of spinal products and technologies provides a modular workflow for posterior stabilization and deformity correction.
ARKEO is designed to optimize fixation and graft integration through anatomical fit, open architecture, and controlled stability.
The Phase 3 trial is evaluating the single-injection biologic candidate for improvements in pain and function.
ANTHEM Elbow is designed to offer surgeons anatomically-contoured plates to treat a variety of fractures, regardless of severity or complexity,
The prodisc C Vivo and prodisc C SK are now indicated for reconstruction of a vertebral disc from C3-C7 following discectomy at one level or two contiguous levels.
Login
Register for a free account
As a guest member you get access to more articles and videos every month.